GLP-1 receptor agonists efficacy in managing comorbidities associated with diabetes mellitus: a narrative review

被引：0
|
作者：
Mahshad Gholami [1 ]
Narges Zargar Balajam [1 ]
Samira Rakhsha [1 ]
Sayed Mahmoud Sajjadi-Jazi [2 ]
Gita Shafiee [1 ]
Ramin Heshmat [1 ]
机构：
[1] Tehran University of Medical Sciences,Chronic Diseases Research Center, Endocrinology and Metabolism Population Sciences Institute
[2] Tehran University of Medical Sciences,Endocrinology and Metabolism Research Center, Endocrinology and Metabolism Clinical Sciences Institute
来源：
Journal of Diabetes & Metabolic Disorders | / 24卷 / 1期
关键词：
Diabetes mellitus; GLP-1; Obesity; Diabetes management;
D O I：
10.1007/s40200-025-01604-w
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [21] Factors Predicting GLP-1 Receptor Agonists Efficacy in Type 2 Diabetes Mellitus Treatment: A Retrospective Observational Study
    Duvnjak, Lea
    Blaslov, Kristina
    DIABETES, 2016, 65 : A572 - A572
  • [22] Efficacy and tolerability of GLP-1 agonists in patients with type 2 diabetes mellitus: an Indian perspective
    Dharmalingam, Mala
    THERAPEUTIC ADVANCES IN ENDOCRINOLOGY AND METABOLISM, 2014, 5 (06) : 159 - 165
  • [23] Novel Therapies in Diabetes: A Comprehensive Narrative Review of GLP-1 Receptor Agonists, SGLT2 Inhibitors, and Beyond
    Olanrewaju, Olusegun A.
    Sheeba, Fnu
    Kumar, Avinash
    Ahmad, Saad
    Blank, Narendar
    Kumari, Reema
    Kumari, Komal
    Salame, Tamara
    Khalid, Ayesha
    Yousef, Nazdar
    Varrassi, Giustino
    Khatri, Mahima
    Kumar, Satish
    Mohamad, Tamam
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2023, 15 (12)
  • [24] Editorial: evolution of GLP-1 receptor agonists as pharmacotherapy for NASH beyond diabetes mellitus and obesity
    Kim, Won
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2021, 54 (11-12) : 1496 - 1497
  • [25] GLP-1 Receptor Agonists for Type 2 Diabetes Mellitus: Recent Developments and Emerging Agents
    Trujillo, Jennifer M.
    Nuffer, Wesley
    PHARMACOTHERAPY, 2014, 34 (11): : 1174 - 1186
  • [26] Effects of GLP-1 receptor agonists on neurological complications of diabetes
    Garcia-Casares, Natalia
    Gonzalez-Gonzalez, Guillermo
    de la Cruz-Cosme, Carlos
    Garzon-Maldonado, Francisco J.
    de Rojas-Leal, Carmen
    Ariza, Maria J.
    Narvaez, Manuel
    Barbancho, Miguel Angel
    Garcia-Arnes, Juan Antonio
    Tinahones, Francisco J.
    REVIEWS IN ENDOCRINE & METABOLIC DISORDERS, 2023, 24 (04): : 655 - 672
  • [27] Effects of GLP-1 receptor agonists on neurological complications of diabetes
    Natalia García-Casares
    Guillermo González-González
    Carlos de la Cruz-Cosme
    Francisco J Garzón-Maldonado
    Carmen de Rojas-Leal
    María J Ariza
    Manuel Narváez
    Miguel Ángel Barbancho
    Juan Antonio García-Arnés
    Francisco J. Tinahones
    Reviews in Endocrine and Metabolic Disorders, 2023, 24 : 655 - 672
  • [28] GLP-1 receptor agonists in the management of Type 2 Diabetes
    Lambert, Lynn
    SA PHARMACEUTICAL JOURNAL, 2016, 83 (02) : 11 - 13
  • [29] Role and development of GLP-1 receptor agonists in the management of diabetes
    Chia, Chee W.
    Egan, Josephine M.
    DIABETES METABOLIC SYNDROME AND OBESITY-TARGETS AND THERAPY, 2009, 2 : 37 - 49
  • [30] Newer GLP-1 receptor agonists and obesity-diabetes
    Brown, Emily
    Cuthbertson, Daniel J.
    Wilding, John P.
    PEPTIDES, 2018, 100 : 61 - 67
12345